Login / Signup

Efficacy of intraperitoneally administered paclitaxel for colorectal cancer with peritoneal metastases.

Koji MuronoHiroaki NozawaHiroshi NagataKazuhiro IshimaruHirofumi SonodaShigenobu EmotoManabu KanekoKazuhito SasakiKensuke OtaniKazushige KawaiKei MuroSoichiro Ishihara
Published in: International journal of colorectal disease (2020)
The ip administration of PTX with systemic chemotherapy can potentially control peritoneal metastases in colorectal cancer.
Keyphrases
  • locally advanced
  • chemotherapy induced
  • radiation therapy
  • rectal cancer